Provides an in-depth review of the 340B program and its impact on reimbursement and community-based practices

Outlines how clinical pathways are developed and used in oncology care decision making

Outlines how clinical guidelines are developed and guide in oncology care decision making

Part 1 of our landscape series provides a big picture on cancer patients today and the novel therapies used to treat them

Details the Enhancing Oncology Model, a CMS value-based payment program

Defines the term “financial toxicity” and how it applies to patients with cancer

Follows an outpatient specialty drug used in cancer from drug manufacturer to patient

Follows a physician-administered drug used in cancer through the pharmaceutical supply chain

Explains the basics of a GPO and the contracting process

Explains how HEOR data may be used by payers and providers to guide decision-making processes

Provides key information on the benefits of electronic health records, especially in relation to quality reporting and the shift to value-based care

Provides a detailed view of the IRA and what it means to the delivery of cancer care, patients, and providers

Details MACRA and the Quality Payment Program as part of the shift towards performance-adjusted payments and away from fee-for-service payments

A deep dive into Medicare infrastructure, including an explanation of how Medicare reimbursement works across different settings

Also known as Buy and Bill, this one details Medicare Part B services and physician reimbursement

Explores the dynamics of Medicare Part D prescription drug programs

Details key information on ACOs, helping providers understand the advantages and disadvantages of different ACO structures

Expalins CMS-approved compendia and off-label use

Part 2 of our landscape series gives a look inside an oncology practice and how it functions, including how patients are administered care and how costs are managed

Details the many policies payers and PBMs may use to contain costs in the pharmacy benefit

Exploration of the term “quality” in the delivery of cancer care, and how it helps identify value based, versus volume based, models of cancer care

Part 3 in our landscape series explores the larger trends affecting oncology practices and how they treat cancer patient today

Outlines the shift to value-based care, explores care frameworks and reimbursement strategies that consider patients' outcomes

Explains the various incentive-based payment programs that are moving providers and healthcare teams from fee-for-service to value-based healthcare

Defines the various terms used in physician-administered drug reimbursement

Defines the terms and what they mean in the distribution process of drugs used in cancer care